No month-end equity selling but likely buying, what if ship breaks, Oil and CTAs Over the past few days, the equity market was fairly weak despite no real change in the macro fundamental outlook. The Fed has remained dovish, the US stimulus was released as planned, and the pandemic and vaccination in the US are steadily improving. The European COVID-19…
J.P. Morgan: Month and Quarter-End Commentary
A financial market resource for the every-day investor and trader.
-
Man Institute: If history is any guide, at this juncture bonds may be a more attractive proposition than equities, at least in the short term.
Seth Golden, , Research Reports, 0
Let’s begin with a mea culpa. In my note of 18 May 2023, I wrote that the risk/reward for equities...
-
Summer Doldrums and Fool-Bearing Price Action
Seth Golden, , Research Reports, 0
The table has turned. In 2022, the S&P 500 (SPX) and peer indices finished the first half of the...
-
Weekly State of the Market: Growth vs. Value & Markets vs. Economy
Seth Golden, , Research Reports, 0
Some 90% of RIAs can’t analyze markets with any proficiency! Some 90% of analysts can’t advise clients in a...
-
Retail Reporting Season Begins With Monthly Retail Sales Ahead
Seth Golden, , Research Reports, 0
“The retailers are reporting, the retailers are reporting”! Some of the biggest names in the retail sector have started...
-
Goldman Sachs: AI poised to begin shifting from ‘excitement’ to ‘deployment’ in 2024
Seth Golden, , Research Reports, 0
At a time when some are calling for a pause on the development of generative artificial intelligence, Jensen Huang,...
-
-
Weekly Warm-up: Turn the Page but Not the Narrative
Seth Golden, , Research Reports, 0
A new year brings new investment opportunities even if the narrative isn’t changing. We still recommend a large cap...
-
J.P. Morgan COVID-19 Forecasts
Seth Golden, , Research Reports, 0
Market and Volatility Commentary COVID-19 forecasts – providing updates and modeling details Given the unprecedented heath crisis and resulting...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00